haloperidol has been researched along with Huntington Disease in 72 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Huntington Disease: A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe the second reported case of neuroleptic malignant syndrome (NMS) related to tetrabenazine therapy in Huntington's disease." | 7.68 | Neuroleptic malignant syndrome related to tetrabenazine introduction and haloperidol discontinuation in Huntington's disease. ( Giménez-Roldán, S; Mateo, D; Muñoz-Blanco, JL, 1992) |
| "We describe the second reported case of neuroleptic malignant syndrome (NMS) related to tetrabenazine therapy in Huntington's disease." | 3.68 | Neuroleptic malignant syndrome related to tetrabenazine introduction and haloperidol discontinuation in Huntington's disease. ( Giménez-Roldán, S; Mateo, D; Muñoz-Blanco, JL, 1992) |
| "However, the performances of Huntington's disease subjects appeared to be different when compared to the other two groups." | 2.69 | Kinematic analysis of the reach to grasp movement in Parkinson's and Huntington's disease subjects. ( Bonfiglioli, C; Castiello, U; De Berti, G; Nichelli, P; Nicoletti, R, 1998) |
| "Six patients with a family history of Huntington's chorea (HC) participated in a double blind crossover trial involving four treatments--lithium carbonate, haloperidol, lithium carbonate and haloperidol, and placebo." | 2.64 | A double blind trial of lithium carbonate and haloperidol in Huntington's chorea. ( Brown, JG; Kidson, MA; Leonard, DP; Shannon, PJ; Taryan, S, 1975) |
| "Pretreatment with haloperidol (2 mg intramuscularly) or sulpiride (100 mg intramuscularly) 30 minutes prior to apomorphine treatment, prevented the therapeutic effect of this compound." | 2.64 | Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptor. ( Cianchetti, C; Corsini, GU; Gessa, G; Mangoni, A; Masala, C; Onali, P, 1978) |
| "We discuss the case of a patient with Huntington's disease and psychosis and comment on the possible types of medication that should be used." | 1.42 | [Psychiatric problems in a motor disorder: psychosis in Huntington's disease]. ( Schadé, A; van der Weijde, E, 2015) |
| "UHDRS (Unified Huntington's Disease Rating Scale) motor scores were obtained from medical records as an index of disease progression." | 1.42 | Examining Huntington's disease patient and informant concordance on frontally mediated behaviors. ( Cimino, CR; Hergert, DC; Sanchez-Ramos, J, 2015) |
| "Here, we report a typical case of 'senile chorea' associated with PAPS, thus expanding the potential underlying etiologies and further narrowing the window of primary 'senile chorea'." | 1.35 | Narrowing the window for 'senile chorea': a case with primary antiphospholipid syndrome. ( Apale, P; Appollonio, I; Capra, M; Ferrarese, C; Frigo, M; Galbussera, A; Gelosa, G; Perego, R; Tremolizzo, L, 2009) |
| "Haloperidol treatment also reduces aggregates formation, an effect that is maintained over time." | 1.35 | Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo. ( Betuing, S; Brouillet, E; Caboche, J; Charvin, D; Déglon, N; Deyts, C; Luthi-Carter, R; Pagès, C; Perrin, V; Régulier, E; Roze, E, 2008) |
| "Striatal neurons in symptomatic Huntington's disease (HD) transgenic mice are resistant to a variety of toxic insults, including quinolinic acid (QA), kainic acid and 3-nitropropionic acid." | 1.31 | Immediate-early gene response to methamphetamine, haloperidol, and quinolinic acid is not impaired in Huntington's disease transgenic mice. ( Costain, WJ; Crocker, SF; Denovan-Wright, EM; Hamilton, LC; MacGibbon, GA; Murphy, KM; Robertson, HA, 2002) |
| "Eighteen patients with Huntington's chorea were examined before and after neuroleptic treatment (haloperidol, pimozide, tiapride) to study the effect of such treatment on hyperkinesia and motor performance." | 1.27 | Effect of neuroleptic treatment on involuntary movements and motor performances in Huntington's disease. ( Caraceni, T; Carella, F; Giovannini, P; Girotti, F; Grassi, MP; Parati, E; Scigliano, G; Soliveri, P, 1984) |
| "Haloperidol treatment decreased chorea but did not affect gait patterns." | 1.27 | The gait abnormality of Huntington's disease. ( Koller, WC; Trimble, J, 1985) |
| "Treatment with haloperidol in all patients and with dipropylacetic acid in three patients did not appear to modify the CSF, HVA, and 5HIAA concentrations, the plasma DBH activity, or the DA uptake." | 1.26 | Biochemical aspects of Huntington's chorea. ( Algeri, S; Branciforti, A; Calderini, G; Caraceni, T; Consolazione, A; Dall'olio, A; Girotti, F; Morselli, PL; Riva, E; Spreafico, R, 1977) |
| "Haloperidol (10(-5)M) was also shown to be a strong non-competitive inhibitor of 14C-DA uptake by platelets." | 1.26 | Platelet dopamine uptake in Huntington's chorea and Gilles de la Tourette's syndrome: effect of haloperidol. ( Barbeau, A; Butterworth, RF; Gonce, M, 1977) |
| "Huntington's disease (Huntington's chorea), a degenerative disorder of the central nervous system, is inherited in an autosomal dominant pattern." | 1.26 | Huntington's disease: current concepts of therapy. ( Goetz, CG; Weiner, WJ, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 50 (69.44) | 18.7374 |
| 1990's | 8 (11.11) | 18.2507 |
| 2000's | 8 (11.11) | 29.6817 |
| 2010's | 4 (5.56) | 24.3611 |
| 2020's | 2 (2.78) | 2.80 |
| Authors | Studies |
|---|---|
| Kadir, A | 1 |
| Singh, J | 1 |
| Rahi, V | 4 |
| Kumar, P | 4 |
| Ram, P | 3 |
| van der Weijde, E | 1 |
| Schadé, A | 1 |
| Hergert, DC | 1 |
| Sanchez-Ramos, J | 1 |
| Cimino, CR | 1 |
| Markianos, M | 3 |
| Panas, M | 3 |
| Kalfakis, N | 3 |
| Vassilopoulos, D | 3 |
| Gelosa, G | 1 |
| Tremolizzo, L | 1 |
| Galbussera, A | 1 |
| Perego, R | 1 |
| Capra, M | 1 |
| Frigo, M | 1 |
| Apale, P | 1 |
| Ferrarese, C | 3 |
| Appollonio, I | 2 |
| Hatzimanolis, J | 1 |
| Jhanjee, A | 1 |
| Anand, KS | 1 |
| Bajaj, BK | 1 |
| VAISBERG, M | 1 |
| SAUNDERS, JC | 1 |
| NAYRAC, P | 2 |
| ARNOTT, G | 2 |
| MILBLED, G | 2 |
| Hussain, N | 1 |
| Flumerfelt, BA | 1 |
| Rajakumar, N | 1 |
| Chou, KL | 1 |
| Borek, LL | 1 |
| Friedman, JH | 1 |
| Korenyi, C | 1 |
| Whittier, JR | 2 |
| Charvin, D | 1 |
| Roze, E | 1 |
| Perrin, V | 1 |
| Deyts, C | 1 |
| Betuing, S | 1 |
| Pagès, C | 1 |
| Régulier, E | 1 |
| Luthi-Carter, R | 1 |
| Brouillet, E | 1 |
| Déglon, N | 1 |
| Caboche, J | 1 |
| Yassa, R | 1 |
| Ananth, J | 1 |
| Kish, SJ | 2 |
| Shannak, KS | 1 |
| Perry, TL | 1 |
| Hornykiewicz, O | 2 |
| Girotti, F | 4 |
| Carella, F | 1 |
| Scigliano, G | 1 |
| Grassi, MP | 1 |
| Soliveri, P | 1 |
| Giovannini, P | 2 |
| Parati, E | 2 |
| Caraceni, T | 4 |
| Frattola, L | 2 |
| Albizzati, MG | 1 |
| Alemani, A | 1 |
| Bassi, S | 1 |
| Trabucchi, M | 1 |
| Meltzer, HY | 1 |
| Barbosa, ER | 1 |
| Marchiori, PE | 1 |
| Scaff, M | 1 |
| de Assis, JL | 1 |
| Majeron, MA | 1 |
| Ambrosoli, C | 1 |
| Armocida, G | 1 |
| Finavera, L | 1 |
| Quisi, Q | 1 |
| Saran, BM | 1 |
| Klein, MS | 1 |
| Benay, EM | 1 |
| Paulson, GW | 1 |
| Piolti, R | 1 |
| Perego, M | 1 |
| Pozzi, C | 1 |
| Rovati, L | 1 |
| Lewis, CF | 1 |
| DeQuardo, JR | 1 |
| Tandon, R | 1 |
| Georgiou, N | 1 |
| Phillips, JG | 1 |
| Bradshaw, JL | 1 |
| Cunnington, R | 1 |
| Chiu, E | 2 |
| Bonelli, RM | 1 |
| Költringer, P | 1 |
| Kenner, L | 1 |
| Reisecker, F | 1 |
| Bonelli, R | 1 |
| Bonfiglioli, C | 1 |
| De Berti, G | 1 |
| Nichelli, P | 1 |
| Nicoletti, R | 1 |
| Castiello, U | 1 |
| Besret, L | 1 |
| Page, KJ | 1 |
| Dunnett, SB | 1 |
| MacGibbon, GA | 1 |
| Hamilton, LC | 1 |
| Crocker, SF | 1 |
| Costain, WJ | 1 |
| Murphy, KM | 1 |
| Robertson, HA | 1 |
| Denovan-Wright, EM | 1 |
| Dill, RE | 1 |
| Dorris, RL | 1 |
| Phillips-Thonnard, I | 1 |
| Murai, Y | 1 |
| Yoshida, M | 1 |
| Yanagisawa, N | 1 |
| Leonard, DP | 2 |
| Kidson, MA | 2 |
| Brown, JG | 1 |
| Shannon, PJ | 2 |
| Taryan, S | 1 |
| Glaeser, BS | 1 |
| Vogel, WH | 1 |
| Oleweiler, DB | 1 |
| Hare, TA | 1 |
| Weitzman, DO | 1 |
| Rosfnfeld, C | 1 |
| Korenyl, C | 1 |
| Kuran, W | 1 |
| Tolosa, ES | 1 |
| Consolo, S | 1 |
| Ladinsky, H | 1 |
| Bianchi, S | 1 |
| Calderini, G | 1 |
| Consolazione, A | 1 |
| Riva, E | 1 |
| Algeri, S | 1 |
| Spreafico, R | 1 |
| Branciforti, A | 1 |
| Dall'olio, A | 1 |
| Morselli, PL | 1 |
| Rosin, AJ | 1 |
| Corsini, GU | 1 |
| Onali, P | 1 |
| Masala, C | 1 |
| Cianchetti, C | 1 |
| Mangoni, A | 1 |
| Gessa, G | 1 |
| Butterworth, RF | 1 |
| Gonce, M | 1 |
| Barbeau, A | 1 |
| Avanzini, G | 1 |
| Mann, J | 1 |
| Goetz, CG | 1 |
| Weiner, WJ | 3 |
| Caraceni, TA | 1 |
| Celano, I | 1 |
| Balboni, L | 1 |
| Calne, DB | 1 |
| Eisler, T | 1 |
| Shoulson, I | 1 |
| Chase, TN | 2 |
| Oke, AF | 1 |
| Putz, C | 1 |
| Adams, RN | 1 |
| Bird, ED | 1 |
| Mateo, D | 2 |
| Muñoz-Blanco, JL | 1 |
| Giménez-Roldán, S | 2 |
| Warsh, JJ | 1 |
| Politsky, JM | 1 |
| Li, PP | 1 |
| Stewart, JT | 1 |
| Mounts, ML | 1 |
| Clark, RL | 1 |
| Barr, AN | 1 |
| Fischer, JH | 1 |
| Koller, WC | 2 |
| Spunt, AL | 1 |
| Singhal, A | 1 |
| Szczepanik-van Leeuwen, PA | 1 |
| Janati, A | 1 |
| Trimble, J | 1 |
| Manyam, NV | 1 |
| Bravo-Fernandez, E | 1 |
| Schenk, G | 1 |
| Leijnse-Ybema, HJ | 1 |
| Brown, J | 1 |
| Kwiatkowska, E | 1 |
| Grochmal-Bachowa, B | 1 |
| Kivalo, E | 1 |
| Weckman, N | 1 |
| Critchley, EM | 1 |
| Clark, DB | 1 |
| Wikler, A | 1 |
| Klawans, HL | 2 |
| Candelise, L | 1 |
| Faglioni, P | 1 |
| Spinnler, H | 1 |
| Vignolo, LA | 1 |
| Ott, J | 1 |
| Müller, E | 1 |
| Heidrich, R | 1 |
| Marsden, CD | 1 |
| Mattsson, B | 1 |
| Persson, SA | 1 |
5 reviews available for haloperidol and Huntington Disease
| Article | Year |
|---|---|
The management of psychosis in movement disorder patients.
Topics: Antipsychotic Agents; Clozapine; Haloperidol; Humans; Huntington Disease; Lewy Body Disease; Parkins | 2007 |
Lithium carbonate in the treatment of movement disorders. A critical review.
Topics: Adult; Aged; Antipsychotic Agents; Clinical Trials as Topic; Deanol; Dopamine; Double-Blind Method; | 1980 |
Dopamine autoreceptor stimulation: clinical significance.
Topics: Apomorphine; Dopamine; Haloperidol; Humans; Huntington Disease; Mental Disorders; Neurons; Parkinson | 1982 |
The pathogensis and medical treatment of extrapyramidal disease.
Topics: Adult; Athetosis; Basal Ganglia Diseases; Caudate Nucleus; Chorea; Corpus Striatum; Dopamine; Dopami | 1979 |
Huntington's disease.
Topics: Adult; Child; Chlordiazepoxide; Diazepam; Dopamine; Female; Genetic Counseling; Haloperidol; Humans; | 1975 |
12 trials available for haloperidol and Huntington Disease
| Article | Year |
|---|---|
Lithium carbonate in the treatment of movement disorders. A critical review.
Topics: Adult; Aged; Antipsychotic Agents; Clinical Trials as Topic; Deanol; Dopamine; Double-Blind Method; | 1980 |
Acute treatment of Huntington's chorea with lisuride.
Topics: Clinical Trials as Topic; Ergolines; Female; Haloperidol; Humans; Huntington Disease; Lisuride; Male | 1983 |
Proglumide, a cholecystokinin receptor antagonist, reduces neuroleptic action in Huntington's chorea.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Drug Therapy, Combination; Female; Haloperidol; Human | 1995 |
Kinematic analysis of the reach to grasp movement in Parkinson's and Huntington's disease subjects.
Topics: Adult; Age of Onset; Aged; Analysis of Variance; Antiparkinson Agents; Basal Ganglia; Chlorpromazine | 1998 |
A double blind trial of lithium carbonate and haloperidol in Huntington's chorea.
Topics: Anger; Carbonates; Clinical Trials as Topic; Depression; Depression, Chemical; Drug Therapy, Combina | 1975 |
Studies on the anti-dyskinesia effect of apomorphine in man.
Topics: Administration, Oral; Adult; Aged; Apomorphine; Clinical Trials as Topic; Drug Evaluation; Female; H | 1976 |
Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptor.
Topics: Adult; Apomorphine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; | 1978 |
2-dimethylaminoethanol (Deanol) in Huntington's chorea.
Topics: Adolescent; Adult; Clinical Trials as Topic; Deanol; Double-Blind Method; Ethanolamines; Female; Hal | 1978 |
[Huntington disease: tetrabenazine compared to haloperidol in the reduction of involuntary movements].
Topics: Adult; Drug Evaluation; Female; Haloperidol; Humans; Huntington Disease; Male; Middle Aged; Random A | 1989 |
Lithium carbonate in Huntington's chorea.
Topics: Activities of Daily Living; Adult; Clinical Trials as Topic; Haloperidol; Humans; Huntington Disease | 1973 |
Letter: Double-blind trial of lithium carbonate and haloperidol in Huntington's chorea.
Topics: Behavior; Carbonates; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Haloperid | 1974 |
Letter: Treatment of Huntington's chorea.
Topics: Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Clinical Trials as Topic; Dia | 1973 |
56 other studies available for haloperidol and Huntington Disease
| Article | Year |
|---|---|
Berberine Ameliorate Haloperidol and 3-Nitropropionic Acid-Induced Neurotoxicity in Rats.
Topics: Animals; Antioxidants; Berberine; Catalase; Haloperidol; Huntington Disease; Motor Activity; Neuropr | 2022 |
Filgrastim, a Recombinant Form of Granulocyte Colony-stimulating Factor, Ameliorates 3-nitropropionic Acid and Haloperidol-induced Striatal Neurotoxicity in Rats.
Topics: Animals; Filgrastim; Granulocyte Colony-Stimulating Factor; Haloperidol; Huntington Disease; Movemen | 2022 |
Filgrastim, a Recombinant Form of Granulocyte Colony-stimulating Factor, Ameliorates 3-nitropropionic Acid and Haloperidol-induced Striatal Neurotoxicity in Rats.
Topics: Animals; Filgrastim; Granulocyte Colony-Stimulating Factor; Haloperidol; Huntington Disease; Movemen | 2022 |
Filgrastim, a Recombinant Form of Granulocyte Colony-stimulating Factor, Ameliorates 3-nitropropionic Acid and Haloperidol-induced Striatal Neurotoxicity in Rats.
Topics: Animals; Filgrastim; Granulocyte Colony-Stimulating Factor; Haloperidol; Huntington Disease; Movemen | 2022 |
Filgrastim, a Recombinant Form of Granulocyte Colony-stimulating Factor, Ameliorates 3-nitropropionic Acid and Haloperidol-induced Striatal Neurotoxicity in Rats.
Topics: Animals; Filgrastim; Granulocyte Colony-Stimulating Factor; Haloperidol; Huntington Disease; Movemen | 2022 |
Filgrastim, a Recombinant Form of Granulocyte Colony-stimulating Factor, Ameliorates 3-nitropropionic Acid and Haloperidol-induced Striatal Neurotoxicity in Rats.
Topics: Animals; Filgrastim; Granulocyte Colony-Stimulating Factor; Haloperidol; Huntington Disease; Movemen | 2022 |
Filgrastim, a Recombinant Form of Granulocyte Colony-stimulating Factor, Ameliorates 3-nitropropionic Acid and Haloperidol-induced Striatal Neurotoxicity in Rats.
Topics: Animals; Filgrastim; Granulocyte Colony-Stimulating Factor; Haloperidol; Huntington Disease; Movemen | 2022 |
Filgrastim, a Recombinant Form of Granulocyte Colony-stimulating Factor, Ameliorates 3-nitropropionic Acid and Haloperidol-induced Striatal Neurotoxicity in Rats.
Topics: Animals; Filgrastim; Granulocyte Colony-Stimulating Factor; Haloperidol; Huntington Disease; Movemen | 2022 |
Filgrastim, a Recombinant Form of Granulocyte Colony-stimulating Factor, Ameliorates 3-nitropropionic Acid and Haloperidol-induced Striatal Neurotoxicity in Rats.
Topics: Animals; Filgrastim; Granulocyte Colony-Stimulating Factor; Haloperidol; Huntington Disease; Movemen | 2022 |
Filgrastim, a Recombinant Form of Granulocyte Colony-stimulating Factor, Ameliorates 3-nitropropionic Acid and Haloperidol-induced Striatal Neurotoxicity in Rats.
Topics: Animals; Filgrastim; Granulocyte Colony-Stimulating Factor; Haloperidol; Huntington Disease; Movemen | 2022 |
[Psychiatric problems in a motor disorder: psychosis in Huntington's disease].
Topics: Antipsychotic Agents; Haloperidol; Humans; Huntington Disease; Male; Middle Aged; Psychotic Disorder | 2015 |
Examining Huntington's disease patient and informant concordance on frontally mediated behaviors.
Topics: Adult; Aged; Antipsychotic Agents; Awareness; Cognition Disorders; Disease Progression; Female; Fron | 2015 |
Plasma homovanillic acid and prolactin in Huntington's disease.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Antipsychotic Agents; Dopamine; Female; Haloperidol; H | 2009 |
Narrowing the window for 'senile chorea': a case with primary antiphospholipid syndrome.
Topics: Age of Onset; Aged; Anti-Dyskinesia Agents; Antibodies, Antiphospholipid; Anticonvulsants; Antiphosp | 2009 |
Neuroendocrine evidence of normal hypothalamus-pituitary dopaminergic function in Huntington's disease.
Topics: Adult; Dopamine; Female; Genetic Predisposition to Disease; Haloperidol; Humans; Huntingtin Protein; | 2010 |
Hypersexual features in Huntington's disease.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Haloperidol; Humans; Huntington Disease; Olanz | 2011 |
TREATMENT OF DYSKINESIAS INCLUDING HUNTINGTON'S CHOREA WITH THIOPROPAZATE AND R-1625.
Topics: Chorea; Dyskinesias; Haloperidol; Humans; Huntington Disease; Movement Disorders; Phenothiazines; Tr | 1963 |
[HUNTINGTON'S CHOREA, HUMOR DISORDERS WITH MANIC MANIFESTATIONS, BENEFICIAL EFFECTS OF HALOPERIDOL (FLUOROPHENYLPIPERIDINOBUTYROPHENONE). ABSENCE OF THE THERAPEUTIC AKINETO-HYPERTONIC SYNDROME].
Topics: Bipolar Disorder; Chlorpromazine; Chorea; Electroencephalography; Electromyography; Haloperidol; Hum | 1964 |
[HUNTINGTON'S CHOREA, TEMPERAMENT DISORDERS OF MANIAC EXPRESSION. BENEFICIAL EFFECTS OF HALOPERIDOL (FLUORO-PHENYL-PIPERIDINE BUTYROPHENONE). ABSENCE OF THE THERAPEUTIC AKINETO-HYPERTONIC SYNDROME].
Topics: Bipolar Disorder; Butyrophenones; Chorea; Drug Therapy; Electromyography; Haloperidol; Humans; Hunti | 1964 |
Glutamatergic regulation of long-term grafts of fetal lateral ganglionic eminence in a rat model of Huntington's disease.
Topics: Animals; Brain Injuries; Brain Tissue Transplantation; Corpus Striatum; Disease Models, Animal; Dizo | 2004 |
Platelet monoamine oxidase activity in subjects tested for Huntington's disease gene mutation.
Topics: Antipsychotic Agents; Base Sequence; Blood Platelets; DNA Primers; Female; Haloperidol; Humans; Hunt | 2004 |
Dyskinesia analysis. Histogram analysis of cineseismograms of human dyskinesia.
Topics: Aged; Anti-Dyskinesia Agents; Dyskinesias; Haloperidol; Humans; Huntington Disease; Male; Mesoridazi | 1974 |
Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo.
Topics: Age Factors; Animals; Antipsychotic Agents; Cell Count; Corpus Striatum; Disease Models, Animal; Dop | 2008 |
Neuronal [3H]benzodiazepine binding and levels of GABA, glutamate, and taurine are normal in Huntington's disease cerebellum.
Topics: Amino Acids; Cerebellum; Flunitrazepam; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Haloperi | 1983 |
Effect of neuroleptic treatment on involuntary movements and motor performances in Huntington's disease.
Topics: Adult; Antipsychotic Agents; Female; Haloperidol; Humans; Huntington Disease; Male; Middle Aged; Mot | 1984 |
[Huntington chorea: report of 16 cases].
Topics: Adult; Aged; Brain Diseases; Chlorpromazine; Dementia; Diagnosis, Differential; Female; gamma-Aminob | 1983 |
[Attempted direct etiological treatment of Huntington's chorea. Case reports].
Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Haloperidol; Humans; Huntington Disea | 1980 |
Clinical evaluation of amantadine and haloperidol in Huntington's chorea.
Topics: Amantadine; Drug Therapy, Combination; Haloperidol; Humans; Huntington Disease; Male | 1980 |
Huntington's disease.
Topics: Adolescent; Adult; Counseling; Haloperidol; Humans; Huntington Disease; Middle Aged | 1980 |
ECT in genetically confirmed Huntington's disease.
Topics: Aged; Alleles; Amoxapine; Combined Modality Therapy; Depressive Disorder; Electroconvulsive Therapy; | 1996 |
Impairments of movement kinematics in patients with Huntington's disease: a comparison with and without a concurrent task.
Topics: Adrenergic Uptake Inhibitors; Adult; Anti-Dyskinesia Agents; Anticonvulsants; Clonazepam; Dothiepin; | 1997 |
Reversible Huntington's disease?
Topics: Antipsychotic Agents; Caudate Nucleus; Disease Progression; Haloperidol; Humans; Huntington Disease; | 1998 |
The problem of antipsychotic treatment for functional imaging in Huntington's disease: receptor binding, gene expression and locomotor activity after sub-chronic administration and wash-out of haloperidol in the rat.
Topics: Animals; Antipsychotic Agents; Autoradiography; Benzazepines; Corpus Striatum; Dopamine Antagonists; | 2000 |
Immediate-early gene response to methamphetamine, haloperidol, and quinolinic acid is not impaired in Huntington's disease transgenic mice.
Topics: Animals; Anti-Dyskinesia Agents; Central Nervous System Stimulants; Corpus Callosum; Corpus Striatum | 2002 |
A pharmacologic model of Huntington's chorea.
Topics: Animals; Carbachol; Catheterization; Clozapine; Corpus Striatum; Disease Models, Animal; Dyskinesia, | 1976 |
[Treatment of chorea (author's transl)].
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Child; Female; Haloperidol; Humans; Huntington Diseas | 1977 |
GABA levels in cerebrospinal fluid of patients with Huntington's chorea: a preliminary report.
Topics: Adult; Aged; Aminobutyrates; Amitriptyline; Chlorpromazine; Diazepam; Female; gamma-Aminobutyric Aci | 1975 |
Quantification of chorea in Huntington's disease by power spectral analysis.
Topics: Adult; Aged; Diazepam; Haloperidol; Humans; Huntington Disease; Mesoridazine; Methods; Middle Aged; | 1976 |
[Modern methods of treating Huntington's chorea].
Topics: gamma-Aminobutyric Acid; Haloperidol; Humans; Huntington Disease; Lithium; Methysergide; Physostigmi | 1976 |
The cerebrospinal fluid choline levels in patients with Huntington's chorea. Negative effect of haloperidol treatment.
Topics: Adult; Choline; Cholinesterases; Female; Haloperidol; Humans; Huntington Disease; Male; Middle Aged | 1977 |
Biochemical aspects of Huntington's chorea.
Topics: Adult; Age Factors; Blood Platelets; Brain Damage, Chronic; Dopamine; Dopamine beta-Hydroxylase; Fem | 1977 |
Treatment of dyskinetic and choreatic movement disorders in adults.
Topics: Adult; Aged; Athetosis; Chorea; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskine | 1978 |
Platelet dopamine uptake in Huntington's chorea and Gilles de la Tourette's syndrome: effect of haloperidol.
Topics: Adolescent; Adult; Blood Platelets; Dopamine; Female; Haloperidol; Humans; Huntington Disease; Kinet | 1977 |
Pharmacology of Huntington's chorea. Personal experience.
Topics: Acetates; Adult; Aminobutyrates; Blood Cell Count; Bromocriptine; Female; gamma-Aminobutyric Acid; H | 1977 |
Platelet monoamine oxidase activity in Huntington's chorea.
Topics: Adult; Aged; Blood Platelets; Female; Haloperidol; Humans; Huntington Disease; Lithium; Male; Middle | 1978 |
Huntington's disease: current concepts of therapy.
Topics: Acetylcholine; Adolescent; Adult; Butyrophenones; Child; Chlorpromazine; Dopamine Antagonists; gamma | 1979 |
Neuroleptic treatment is an unlikely cause of elevated dopamine in thalamus of schizophrenic subjects.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Dopamine; Haloperidol; Humans; Huntington Disease | 1992 |
Neuroleptic malignant syndrome related to tetrabenazine introduction and haloperidol discontinuation in Huntington's disease.
Topics: Female; Haloperidol; Humans; Huntington Disease; Middle Aged; Neuroleptic Malignant Syndrome; Substa | 1992 |
Reduced striatal [3H]inositol 1,4,5-trisphosphate binding in Huntington's disease.
Topics: Brain; Corpus Striatum; Female; Haloperidol; Humans; Huntington Disease; Inositol 1,4,5-Trisphosphat | 1991 |
Aggressive behavior in Huntington's disease: treatment with propranolol.
Topics: Adult; Aggression; Antipsychotic Agents; Drug Therapy, Combination; Haloperidol; Humans; Huntington | 1987 |
Serum haloperidol concentration and choreiform movements in Huntington's disease.
Topics: Adult; Aged; Female; Haloperidol; Humans; Huntington Disease; Male; Middle Aged; Movement; Osmolar C | 1988 |
Improved gas chromatographic-mass spectrometric assay for haloperidol utilizing ammonia chemical ionization and selected-ion monitoring.
Topics: Ammonia; Chemical Phenomena; Chemistry; Gas Chromatography-Mass Spectrometry; Haloperidol; Humans; H | 1985 |
Kluver-Bucy syndrome in Huntington's chorea.
Topics: Adult; Agnosia; Behavior; Dementia; Dopamine; Feeding Behavior; Haloperidol; Humans; Huntington Dise | 1985 |
The gait abnormality of Huntington's disease.
Topics: Adult; Aged; Gait; Haloperidol; Humans; Huntington Disease; Male; Middle Aged | 1985 |
Letter: Huntington's chorea and levodopa.
Topics: Carboxy-Lyases; Dihydroxyphenylalanine; Drug Interactions; Drug Therapy, Combination; Haloperidol; H | 1974 |
[Huntington's chorea: personal observations on its juvenile form].
Topics: Child; Haloperidol; Humans; Huntington Disease; Male | 1970 |
[Use of haloperidol in the treatment of extrapyramidal compulsive movement].
Topics: Adult; Aged; Chorea; Extrapyramidal Tracts; Female; Haloperidol; Humans; Huntington Disease; Hyperki | 1970 |
An adult form of acanthocytosis.
Topics: Abetalipoproteinemia; Adult; Ataxia; Diazepam; Female; Haloperidol; Humans; Huntington Disease; Hydr | 1967 |
Lingual-facial-buccal movements in the elderly. I. Pathophysiology and treatment.
Topics: Aged; Amphetamine; Chemoreceptor Cells; Chlorpromazine; Corpus Striatum; Dopamine Antagonists; Facia | 1973 |
Central monoamine metabolism in man. Effect of putative dopamine receptor agonists and antagonists.
Topics: Adult; Basal Ganglia Diseases; Brain; Central Nervous System Diseases; Dopamine; Haloperidol; Homova | 1973 |
The effect of d-amphetamine on choreiform movement disorders.
Topics: Adolescent; Adult; Child; Chorea; Corpus Striatum; Dextroamphetamine; Dopamine; Evaluation Studies a | 1974 |
[Differential diagnosis of acute extrapyramidal motor disorders in children. A case study].
Topics: Acute Disease; Adolescent; Basal Ganglia Diseases; Diagnosis, Differential; Female; Haloperidol; Hep | 1974 |
Drug treatment of diseases characterized by abnormal movements.
Topics: Chorea; Diazepam; Ethanol; Haloperidol; Humans; Huntington Disease; Levodopa; Movement Disorders; My | 1973 |
Cerebrospinal homovanillic acid and 5-hydroxyindoleacetic acid in huntington's chorea.
Topics: Adult; Chlormethiazole; Chlorpromazine; Female; Fluphenazine; Haloperidol; Homovanillic Acid; Humans | 1974 |